Univercells Technologies
Pre-clinicalWe deliver the next generation of bioprocess technologies by leveraging the strengths of process intensification and chaining
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $60.6M
About
We deliver the next generation of bioprocess technologies by leveraging the strengths of process intensification and chaining
BiologicsVaccines
Funding History
3Total raised:$60.6M
Series B$40MSep 15, 2021
Grant$5.6MOct 15, 2020
Series A$15MJun 15, 2018